Advanced search
Publication Cover
Ocular Immunology and Inflammation Volume 15, 2007 - Issue 5
Submit an article Journal homepage
200
Views
42
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

The Use of Low-Dose Azathioprine in Patients with Vogt-Koyanagi-Harada Disease

Sang Jin Kim Department of Ophthalmology, College of Medicine and Medical Research Center, Seoul National University, Seoul, Korea
, MD &
Hyeong Gon Yu Department of Ophthalmology, College of Medicine and Medical Research Center, Seoul National University, Seoul, Korea; Seoul Artificial Eye Center, Seoul National University Hospital Clinical Research Institute, Seoul, Korea
, MD, PhD
Pages 381-387 | Accepted 06 Aug 2007, Published online: 08 Jul 2009

REFERENCES

  • Moorthy R S, Inomata H, Rao N A. Vogt-Koyanagi-Harada syndrome. Surv Ophthalmol. 1995; 39: 265–292
  • Damico F M, Kiss S, Young L H. Vogt-Koyanagi-Harada disease. Semin Ophthalmol. 2005; 20: 183–190
  • Read R W. Vogt-Koyanagi-Harada disease. Ophthalmol Clin North Am 2002; 15: 333–341
  • Read R W, Yu F, Accorinti M, Bodaghi B, Chee S P, Fardeau C, et al. Evaluation of the effect on outcomes of the route of administration of corticosteroids in acute Vogt-Koyanagi-Harada disease. Am J Ophthalmol 2006; 142: 119–124
  • Yang P, Ren Y, Li B, Fang W, Meng Q, Kijlstra A. Clinical characteristics of Vogt-Koyanagi-Harada syndrome in Chinese patients. Ophthalmology. 2007; 114: 606–614
  • Bykhovskaya I, Thorne J E, Kempen J H, Dunn J P, Jabs D A. Vogt-Koyanagi-Harada disease: clinical outcomes. Am J Ophthalmol. 2005; 140: 674–678
  • Wakatsuki Y, Kogure M, Takahashi Y, Oguro Y. Combination therapy with cyclosporin A and steroid in severe case of Vogt-Koyanagi-Harada's disease. Jpn J Ophthalmol 1988; 32: 358–360
  • Paredes I, Ahmed M, Foster C S. Immunomodulatory therapy for Vogt-Koyanagi-Harada patients as first-line therapy. Ocul Immunol Inflamm. 2006; 14: 87–90
  • Read R W, Rao N A, Cunningham E T, Jr. Vogt Koyanagi Harada disease. Curr Opin Ophthalmol 2000; 11: 437–442
  • Wakefield D, McCluskey P, Reece G. Cyclosporin therapy in Vogt Koyanagi Harada disease. Aust N Z J Ophthalmol. 1990; 18: 137–142
  • Agarwal M, Ganesh S K, Biswas J. Triple agent immunosuppressive therapy in Vogt-Koyanagi-Harada syndrome. Ocul Immunol Inflamm 2006; 14: 333–339
  • Rao N A, Buddi R. Treatment of uveitis with immunosuppressive agents. Indian J Ophthalmol. 1993; 41: 107–113
  • Jabs D A, Rosenbaum J T, Foster C S, Holland G N, Jaffe G J, Louie J S, et al. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol. 2000; 130: 492–513
  • Lustig M J, Cunningham E T, Jr. Use of immunosuppressive agents in uveitis. Curr Opin Ophthalmol 2003; 14: 399–412
  • Okada A A. Immunomodulatory therapy for ocular inflammatory disease: a basic manual and review of the literature. Ocul Immunol Inflamm. 2005; 13: 335–351
  • Andrasch R H, Pirofsky B, Burns R P. Immunosuppressive therapy for severe chronic uveitis. Arch Ophthalmol. 1978; 96: 247–251
  • Yazici H, Pazarli H, Barnes C G, Tuzun Y, Ozyazgan Y, Silman A, et al. A controlled trial of azathioprine in Behçet's syndrome. N Engl J Med. 1990; 322: 281–285
  • Singh G, Fries J F, Spitz P, Williams C A. Toxic effects of azathioprine in rheumatoid arthritis: a national post-marketing perspective. Arthritis Rheum. 1989; 32: 837–843
  • Read R W, Holland G N, Rao N A, Tabbara K F, Ohno S, Arellanes-Garcia L, et al. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol 2001; 131: 647–652
  • Sugiura S. Vogt-Koyanagi-Harada disease. Jpn J Ophthalmol. 1978; 22: 9–35
  • The Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 2005; 140: 509–516
  • Wider R L. Treatment of patients with rheumatoid arthritis refractory to standard therapy. JAMA. 1988; 259: 2446–2449
  • Read R W, Rechodouni A, Butani N, Johnston R, La Bree L D, Smith R E, et al. Complications and prognostic factors in Vogt-Koyanagi-Harada disease. Am J Ophthalmol. 2001; 131: 599–606
  • Kuo I C, Rechdouni A, Rao N A, Johnston R H, Margolis T P, Cunningham E T, Jr. Subretinal fibrosis in patients with Vogt-Koyanagi-Harada disease. Ophthalmology 2000; 107: 1721–1728
  • Lertsumitkul S, Whitcup S M, Nussenblatt R B, Chan C C. Subretinal fibrosis and choroidal neovascularization in Vogt-Koyanagi-Harada syndrome. Graefes Arch Clin Exp Ophthalmol. 1999; 237: 1039–1045
  • Dees C, Arnold J J, Forrester J V, Dick A D. Immunosuppressive treatment of choroidal neovascularization associated with endogenous posterior uveitis. Arch Ophthalmol. 1998; 116: 1456–1461

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.